Search hospitals > Indiana > Indianapolis
Indiana University School of Medicine
Claim this profileIndianapolis, Indiana 46202
Global Leader in Alzheimer's Disease
Global Leader in Diabetes
Conducts research for Dementia
Conducts research for Cancer
Conducts research for Fibrosis
232 reported clinical trials
26 medical researchers
Summary
Indiana University School of Medicine is a medical facility located in Indianapolis, Indiana. This center is recognized for care of Alzheimer's Disease, Diabetes, Dementia, Cancer, Fibrosis and other specialties. Indiana University School of Medicine is involved with conducting 232 clinical trials across 352 conditions. There are 26 research doctors associated with this hospital, such as Monika Fischer, Raj Vuppalanchi, MD, Jared Brosch, and Naga Chalasani, MD.Area of expertise
1Alzheimer's Disease
Global LeaderPSEN2 positive
APP positive
PSEN1 positive
2Diabetes
Global LeaderTop PIs
Monika FischerIndiana University2 years of reported clinical research
Studies Crohn's Disease
Studies Ulcerative Colitis
12 reported clinical trials
14 drugs studied
Raj Vuppalanchi, MDIndiana University School of Medicine1 year of reported clinical research
Studies Liver Disease
Studies Non-alcoholic Fatty Liver Disease
10 reported clinical trials
11 drugs studied
Jared BroschIndiana University School of Medicine3 years of reported clinical research
Studies Alzheimer's Disease
Studies Dementia
9 reported clinical trials
17 drugs studied
Naga Chalasani, MDIndiana University1 year of reported clinical research
Studies Fatty Liver Disease
Studies Non-alcoholic Fatty Liver Disease
7 reported clinical trials
12 drugs studied
Clinical Trials running at Indiana University School of Medicine
Alzheimer's Disease
Ulcerative Colitis
Diabetes
Neurofibromatosis
Oligodendroglioma
Ulcer
Inflammatory Bowel Disease
Dementia
Atopic Dermatitis
Seizures
AVP-786
for Agitation in Alzheimer's Disease
This study is evaluating whether a drug may help reduce the risk of heart attack and stroke in individuals with heart disease.
Recruiting2 awards Phase 37 criteria
Aducanumab
for Alzheimer's Disease
The primary objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score as compared with placebo in participants with early Alzheimer's disease.
Recruiting1 award Phase 31 criteria
Lecanemab
for Alzheimer's Disease
This study is evaluating whether a drug may help reduce the buildup of amyloid plaques in the brain.
Recruiting1 award Phase 39 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Indiana University School of Medicine?
Indiana University School of Medicine is a medical facility located in Indianapolis, Indiana. This center is recognized for care of Alzheimer's Disease, Diabetes, Dementia, Cancer, Fibrosis and other specialties. Indiana University School of Medicine is involved with conducting 232 clinical trials across 352 conditions. There are 26 research doctors associated with this hospital, such as Monika Fischer, Raj Vuppalanchi, MD, Jared Brosch, and Naga Chalasani, MD.